Atherosclerotic Cardiovascular Disease (ASCVD) Risk Management, Part 1From July 2016, Creme de la Thyroid
Discuss an evidence based approch to atheroscelotic cardiovascular disase risk managment. •15min 38Spencer Blackman, MD and Rob Orman, MD
Atherosclerotic Cardiovascular Disease (ASCVD) Risk Management, Part 2From July 2016, Creme de la Thyroid
Part 2 of our conversation with Spencer Blackman on his group’s approach to ASCVD risk management including: specific cases, the role of niacin, and shared decision making. •9min 32Spencer Blackman, MD and Rob Orman, MD
Paper Chase 2: Long-Term Primary Prevention Benefits of Statin TherapyFrom June 2016, C Diff Shows No Mercy!
Statin treatment for five years was associated with a legacy benefit with improved survival and a substantial reduction in cardiovascular disease outcomes over a 20-year period. •5min 5Andrew Buelt, DO and Joe Weatherly, DO